These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6294764)

  • 21. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
    Beggs WH; Sarosi GA
    Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The activity of ketoconazole in mixed cultures of fungi and human fibroblasts.
    Aerts F; De Brabander M; van den Bossche H; van Cutsem J; Borgers M
    Mykosen; 1980 Feb; 23(2):53-67. PubMed ID: 6247651
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
    Herrera-Arellano A; Jiménez-Ferrer E; Zamilpa A; Martínez-Rivera Mde L; Rodríguez-Tovar AV; Herrera-Alvarez S; Salas-Andonaegui ML; Nava-Xalpa MY; Méndez-Salas A; Tortoriello J
    Planta Med; 2009 Apr; 75(5):466-71. PubMed ID: 19189246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans.
    de Brabander M; Aerts F; van Cutsem J; van den Bossche H; Borgers M
    Sabouraudia; 1980 Sep; 18(3):197-210. PubMed ID: 6254187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.
    Krajewska-Kułak E; Niczyporuk W
    Arzneimittelforschung; 1993 Jul; 43(7):782-3. PubMed ID: 8369013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal agents. VI. In vitro antifungal activities of halobenzoyl esters of cis- and trans-[2-(1,1'-biphenyl-4-yl)-2-(1H-imidazol-1-ylmethyl)-1,3- dioxolan-4-yl]carbinols.
    Stefancich G; Silvestri R; Pagnozzi E; Artico M; Retico A; Apuzzo G; Simonetti N
    Farmaco; 1993 Aug; 48(8):1103-12. PubMed ID: 8216672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates.
    Pfaller MA; Segal JJ; Krogstad DJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):917-9. PubMed ID: 6295271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
    Seyfarth F; Schliemann S; Elsner P; Hipler UC
    Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketoconazole resistance.
    Lancet; 1982 Oct; 2(8301):770-1. PubMed ID: 6125840
    [No Abstract]   [Full Text] [Related]  

  • 34. [Preliminary experiments on the mode of action of oxalysine on Candida albicans and C. parapsilosis].
    Zhang H; Gu X; Wang Q; Becker JM
    Wei Sheng Wu Xue Bao; 1993 Dec; 33(6):411-7. PubMed ID: 8203133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of ketoconazole in hair from orally treated rats and guinea pigs (author's transl)].
    Van Cutsem J; Van der Flaes M; Thienpont D; Dony J; Hörig C
    Mykosen; 1980 Aug; 23(8):418-25. PubMed ID: 6252461
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
    Macura AB; Dwernicka B
    Med Dosw Mikrobiol; 1989; 41(1):67-70. PubMed ID: 2668662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fungicidal effect of three new synthetic cationic peptides against Candida albicans.
    Nikawa H; Fukushima H; Makihira S; Hamada T; Samaranayake LP
    Oral Dis; 2004 Jul; 10(4):221-8. PubMed ID: 15196144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
    Cao B; Tsang PW; Tsang DN; Samaranayake LP; Wang J
    Microbios; 1996; 87(352):161-7. PubMed ID: 9050253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro anti-fungal activity of the econazole-ornidazole combination (1:10 ratio)].
    Piccolomini R; Arpini A; Cellini L; Pagano M
    Boll Ist Sieroter Milan; 1983 Jul; 62(3):257-61. PubMed ID: 6639779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "In vitro" antimycotic activity of fenticonazole (Rec 15/1476).
    Costa AL
    Mykosen; 1982 Jan; 25(1):47-52. PubMed ID: 7040949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.